The Grace Study is a clinical research study currently enrolling adults ages 18 to 80 who have been diagnosed with endogenous Cushing syndrome. See study details here.
Also see their website here: https://cushingresearch.com/
Also see their website here: https://cushingresearch.com/

Corcept Therapeutics is committed to improving patient lives through the discovery and development of drugs that address serious unmet medical needs related to excess cortisol activity. Visit www.Corcept.com for more information.